Expression and functional analysis of toll-like receptor 4 in human cervical carcinoma

Journal of Membrane Biology

Volumn 247, Issue 7, 2014, Pages 591-599

  Wang, Yongjun ^a   Weng, Yanjie ^b   Shi, Ying ^b   Xia, Xi ^c   Wang, Shixuan ^b   Duan, Hua ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c The 6th Affiliated Hospital of Shenzhen University Health Science Center   (China)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; HPV; Lipopolysaccharide; Toll like receptor 4

Indexed keywords

TOLL LIKE RECEPTOR 4; LIPOPOLYSACCHARIDE;

APOPTOSIS; ARTICLE; CELL CYCLE; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; PROTEIN EXPRESSION; STROMA; UTERINE CERVIX CARCINOMA; ADULT; CANCER GRADING; CANCER STAGING; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

ADULT; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; TOLL-LIKE RECEPTOR 4; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84903646572     PISSN: 00222631     EISSN: 14321424     Source Type: Journal    
DOI: 10.1007/s00232-014-9675-7     Document Type: Article

References (38)

1. Alfonso-Loeches S, Pascual-Lucas M, Blanco AM, Sanchez-Vera I, Guerri C (2010) Pivotal role of tlr4 receptors in alcohol-induced neuroinflammation and brain damage. J Neurosci 30(24):8285-8295
2. Andersen JM, Al-Khairy D, Ingalls RR (2006) Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Biol Reprod 74(5):824-831
3. Bachmann A, Hanke B, Zawatzky R, Soto U, van Riggelen J, Zur Hausen H, Rosl F (2002) Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells. J Virol 76(1):280-291 (Pubitemid 33139013)
4. Donders GGG, Vereecken A, Bosmans E, Spitz B (2003) Vaginal cytokines in normal pregnancy. Am J Obstet Gynecol 189(5):1433-1438 (Pubitemid 37542186)
5. Fazeli A, Bruce C, Anumba DO (2005) Characterization of Toll-like receptors in the female reproductive tract in humans. Hum Reprod 20(5):1372-1378 (Pubitemid 40790266)
6. Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls RR (2002) Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J Immunol 168(5):2424-2432 (Pubitemid 34171846)
7. Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy S, Hsu D, Xu R, Harpaz N, Dannenberg AJ et al (2007) Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133(6):1869-1881
8. Fukata M, Hernandez Y, Conduah D, Cohen J, Chen AL, Breglio K, Goo T, Hsu D, Xu RL, Abreu MT (2009) Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm Bowel Dis 15(7):997-1006
9. Goto Y, Arigami T, Kitago M, Nguyen SL, Narita N, Ferrone S, Morton DL, Irie RF, Hoon DSB (2008) Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther 7(11):3642-3653
10. Hasan UA, Bates E, Takeshita F, Biliato A, Accardi R, Bouvard V, Mansour M, Vincent I, Gissmann L, Iftner T et al (2007) TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J Immunol 178(5):3186-3197 (Pubitemid 46333201)
11. He WG, Liu QY, Wang L, Chen W, Li N, Cao XT (2007) TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44(11):2850-2859 (Pubitemid 46412506)
12. Huang B, Zhao J, Li HX, He KL, Chen YB, Mayer L, Unkeless JC, Xiong HB (2005) Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 65(12):5009-5014 (Pubitemid 40827306)
13. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90
14. Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, Chan S, Visintin I, Rutherford T, Mor G (2006) TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 66(7):3859-3868
15. Kim WY, Lee JW, Choi JJ, Choi CH, Kim TJ, Kim BG, Song SY, Bae DS (2008) Increased expression of Toll-like receptor 5 during progression of cervical neoplasia. Int J Gynecol Cancer 18(2):300-305 (Pubitemid 351365208)
16. MacRedmond R, Greene C, Taggart CC, McElvaney N, O'Neill S (2005) Respiratory epithelial cells require Toll-like receptor 4 for induction of human beta-defensin 2 by Lipopolysaccharide. Respir Res 6(1):116
17. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436-444
18. Mempel M, Voelcker V, Kollisch G, Plank C, Rad R, Gerhard M, Schnopp C, Fraunberger P, Walli AK, Ring J et al (2003) Tolllike receptor expression in human keratinocytes: Nuclear factor kappa B controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Investig Dermatol 121(6):1389-1396 (Pubitemid 38005491)
19. Mukherjee S, Vaishnava S, Hooper LV (2008) Multi-layered regulation of intestinal antimicrobial defense. Cell Mol Life Sci 65(19):3019-3027
20. Netea MG, Van der Meer JWM, Kullberg BJ (2004) Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol 12(11):484-488 (Pubitemid 39370729)
21. Ohashi K, Burkart V, Flohe S, Kolb H (2000) Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164(2):558-561 (Pubitemid 30043672)
22. O'Neill LAJ (2008) When signaling pathways collide: positive and negative regulation of Toll-like receptor signal transduction. Immunity 29(1):12-20
23. Park JS, Gamboni-Robertson F, He QB, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A et al (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol-Cell Physiol 290(3):C917-C924
24. Pioli PA, Amiel E, Schaefer TM, Connolly JE, Wira CR, Guyre PM (2004) Differential expression of toll-like receptors 2 and 4 in tissues of the human female reproductive tract. Infect Immun 72(10):5799-5806 (Pubitemid 39303691)
25. Pivarcsi A, Bodai L, Rethi B, Kenderessy-Szabo A, Koreck A, Szell M, Beer Z, Bata-Csorgo Z, Magocsi M, Rajnavolgyi E et al (2003) Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 15(6):721-730 (Pubitemid 36675803)
26. Rakoff-Nahoum S, Medzhitov R (2009) Toll-like receptors and cancer. Nat Rev Cancer 9(1):57-63
27. Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, Muller-Hermelink HK, Eck M (2004) Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 136(3):521-526 (Pubitemid 38703687)
28. Soto U, Das BC, Lengert M, Finzer P, Zur Hausen H, Rosl F (1999) Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex. Oncogene 18(21):3187-3198 (Pubitemid 29286963)
29. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H (2002) HSP70 as endogenous stimulus of the toll/interleukin-1 receptor signal pathway. J Biol Chem 277(17):15107-15112 (Pubitemid 34952589)
30. Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, Bode B, Manietta N, Walter J, Schulz-Schaffer W et al (2007) Role of the toll-like receptor 4 in neuro-inflammation in Alzheimer's disease. Cell Physiol Biochem 20(6):947-956 (Pubitemid 350059737)
31. Werner J, Decarlo CA, Escott N, Zehbe I, Ulanova M (2012) Expression of integrins and Toll-like receptors in cervical cancer: effect of infectious agents. Innate Immun 18(1):55-69
32. Whiteside TL (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene 27(45):5904-5912
33. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L (2005) Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 206(1):306-335 (Pubitemid 41105178)
34. Wolfs T, Buurman WA, van Schadewijk A, de Vries B, Daemen M, Hiemstra PS, van't Veer C (2002) In vivo expression of toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 168(3):1286-1293 (Pubitemid 34094497)
35. Ye SM, Hao X, Zhou T, Wu MF, Wei JC, Wang YJ, Zhou L, Jiang XF, Ji L, Chen Y et al (2010) Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion. BMC Cancer 10(1):611
36. Yu L, Chen SW (2008) Toll-like receptors expressed in tumor cells: targets for therapy. Cancer Immunol Immunother 57(9):1271-1278
37. Yu L, Wang LT, Li MZ, Zhong JM, Wang Z, Chen SW (2010) Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia. Cancer Immunol Immunother 59(7):1021-1028
38. Zariffard MR, Novak RM, Lurain N, Sha BE, Graham P, Spear GT (2005) Induction of tumor necrosis factor-alpha secretion and Toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. J Infect Dis 191(11):1913-1921 (Pubitemid 40705400)